Héroux-Devtek (TSE:HRX – Free Report) had its target price upped by National Bankshares from C$23.00 to C$25.00 in a research report released on Tuesday, BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.
HRX has been the subject of several other research reports. Scotiabank raised their price target on Héroux-Devtek from C$21.00 to C$22.50 and gave the stock an outperform rating in a research report on Wednesday, April 10th. TD Securities raised Héroux-Devtek from a hold rating to a buy rating and raised their price target for the stock from C$19.00 to C$23.00 in a research report on Thursday, February 8th. Finally, Desjardins raised their price target on Héroux-Devtek from C$21.00 to C$26.00 and gave the stock a buy rating in a research report on Thursday, February 8th.
Check Out Our Latest Stock Analysis on Héroux-Devtek
Héroux-Devtek Stock Performance
Héroux-Devtek (TSE:HRX – Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported C$0.27 earnings per share for the quarter, beating the consensus estimate of C$0.17 by C$0.10. Héroux-Devtek had a return on equity of 6.05% and a net margin of 3.97%. The firm had revenue of C$163.52 million during the quarter, compared to the consensus estimate of C$148.55 million. Sell-side analysts expect that Héroux-Devtek will post 1.0745934 EPS for the current fiscal year.
Héroux-Devtek Company Profile
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
Further Reading
- Five stocks we like better than Héroux-Devtek
- How to Start Investing in Real Estate
- Silicon Motion Proves That AI in Motion Stays in Motion
- Compound Interest and Why It Matters When Investing
- Undervalued UnitedHealth Group Won’t Be For Long
- Stock Splits, Do They Really Impact Investors?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Héroux-Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Héroux-Devtek and related companies with MarketBeat.com's FREE daily email newsletter.